| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 02/26/2004 | US20040038930 Freeze drying the buffered complex, e.g., ferric hydroxide sucrose, sodium ferric gluconate or ferric saccharate, for subsequent reconstitution for parenteral injection; treating iron deficiency anemia |
| 02/26/2004 | US20040038913 Remedies for lung cancer |
| 02/26/2004 | US20040037910 Higher concentrations of oak bark ash extract, i.e., >20% by weight, skin cancers; antiulcer agents; mixtures of calcium, potassium, and zinc ions as a topical wound healing agent; gangrene; pssoriasis; impetigo; precancerous skin |
| 02/26/2004 | US20040037898 Compositions of oak bark extract, related synthetic compositions and method of using same |
| 02/26/2004 | US20040037897 Treatment of drug resistant organisms |
| 02/26/2004 | US20040037896 Intravenous injection of lignocaine (lidocaine) or a salt, ester or metabolite for use in initiating the natural capacity to regenerate collateral blood vessels; cerebral arterial occlusions; artherosclerosis; angina pectoris |
| 02/26/2004 | US20040037895 Methods of treating involuntary facial spasms and facial wrinkles |
| 02/26/2004 | US20040037892 Oral administration of a mixture of octadeca-9,11-dienoic acid (CLA), docosahexaenoic acid, vitamins E, C, B6 and B12, folic acid and calcium; dietary supplements; cardiovascular disorders; anticholesterol and hypotensive agents |
| 02/26/2004 | US20040037891 Storage stability at about room temperature and a pH range of 6.0-8.8; ophthalmic solution for vision defects and cleaning contact lenses; wound healing agents; antiulcer agents; antiscarring agents; bactericides; fungicides |
| 02/26/2004 | US20040037836 Comprises nitroglycerin; for preventing adverse effects associated with medical device implantation; for inhibiting platelet deposition; angiotensin converting enzyme inhibitors |
| 02/26/2004 | DE10336778A1 Inhalable medicament for stabilizing patients, e.g. during operations, useful e.g. for treating hypotension, shock, ischemia or reperfusion damage, comprising xenon |
| 02/26/2004 | DE10336777A1 Inhalable cardiac medicament, useful e.g. for myocardial protection or treatment of cardiac insufficiency or infarction, comprising xenon or gas mixture containing xenon |
| 02/26/2004 | DE10336768A1 Medicament for improving oxygen utilization in the body, useful e.g. in combating ischemia or reperfusion damage, comprising xenon, optionally together with oxygen or nitrogen monoxide source |
| 02/26/2004 | DE10329926A1 Combination medicament, useful e.g. as anesthetic, sedative or hypnotic, comprising xenon (or gas mixture containing xenon) and dexmedetomidine |
| 02/26/2004 | DE10238161A1 Mucosal or topical administration of minerals, e.g. for treating muscle spasms, psoriasis or osteoporosis or promoting wound healing, comprises direct application of mineral solution from ampoule |
| 02/26/2004 | CA2495435A1 Nutritional supplement for adolescents |
| 02/26/2004 | CA2494992A1 Rare earth metal compounds, methods of making, and methods of using the same |
| 02/25/2004 | EP1391426A1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 02/25/2004 | EP1391213A1 Compositions and methods for treating cancer using maytansinoid CD44 antibody immunoconjugates and chemotherapeutic agents |
| 02/25/2004 | EP1391206A1 Pharmaceutical compositions comprising arsenic for the treatment of lymphoma |
| 02/25/2004 | EP1390081A2 Therapeutic and diagnostic compounds, compositions, and methods |
| 02/25/2004 | EP1390075A2 Chemotherapeutic induction of egr-1 promoter activity |
| 02/25/2004 | EP1390027A1 Composition comprising demethylcantharidin in combination with platinum-containing anticancer agents and use thereof |
| 02/25/2004 | EP1390013A2 Therapeutic treatments using the direct application of antimicrobial metal compositions |
| 02/25/2004 | EP1390008A2 Pharmaceutical and cosmetic compositions against skin aging |
| 02/25/2004 | EP1390007A1 Cosmetic composition based on zinc and copper sulphates and sucralphate |
| 02/25/2004 | EP1137341B1 Baby food stimulating growth of the thymus |
| 02/25/2004 | EP0988797B1 Use of compositions for postgastrectomic mineral supply |
| 02/25/2004 | EP0980260B1 Pharmaceutical composition for treating parkinson's disease or depression |
| 02/25/2004 | CN1477959A Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases |
| 02/25/2004 | CN1477950A Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of critically ill, chronically ill and people with malnutrition |
| 02/25/2004 | CN1476889A Medicine for external application for curing cervical erosion |
| 02/25/2004 | CN1476866A Medicine with acupuncture and moxibustion effect and its preparation method |
| 02/25/2004 | CN1476843A Application of nano copper powder in preparation of immunopotentiator medicine |
| 02/25/2004 | CN1139400C Medicine for treating arthritis and bone injury disease |
| 02/25/2004 | CN1139392C Quick-acting bone-setting powder medicine |
| 02/24/2004 | US6696419 Applying calcium fructoborate or calcium threonine borate, to skins for therapy of inflammation of joints or injuries; transdermal drug delivery |
| 02/24/2004 | US6696071 Pre-coital and post-coital rinse with anti-viral and skin-protective zinc salts |
| 02/24/2004 | US6696055 Disinfectant substance comprising an iodine impregnated resin for use in sterilizing a fluid such as water or air |
| 02/24/2004 | US6696041 Treatment of colds, flu like infections and other general nasal based infections with a solution containing iodine and other broad spectrum microbicides and a method for its use |
| 02/24/2004 | CA2305750C Stable solution of zinc and bicarbonate ions |
| 02/19/2004 | WO2004015089A2 Polyionic organic acid formulations |
| 02/19/2004 | WO2004014430A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | WO2004014413A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 02/19/2004 | WO2004014402A1 Activated carbon for preventing pregnancy and sexually transmitted disease |
| 02/19/2004 | WO2004014401A1 Metal cluster nano-compounds for treating tumor diseases |
| 02/19/2004 | WO2004014386A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies |
| 02/19/2004 | WO2004014352A2 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | WO2003099223A3 Copper lowering treatment of inflammatory and fibrotic diseases |
| 02/19/2004 | WO2003049593A3 Prevention of flap necrosis in plastic surgery |
| 02/19/2004 | WO2002090514A8 Epidermal growth factor receptorantisense oligonucleotides |
| 02/19/2004 | US20040033520 Diagnosing metastatic colorectal, stomach and/or esophageal cancer in vitro; immunoassay; radioimaging tumors; immunotherapeutics; genetic vaccines |
| 02/19/2004 | US20040033272 Containing sources of the metal ions; useful for treating muscular, neuromuscular or osseous etiology that directly or indirectly affect the muscles and bones. |
| 02/19/2004 | US20040033271 Methods for contemporaneous administration of levamisole and 5-fluorouracil |
| 02/19/2004 | US20040033268 Hypertonic sodium chloride, a molecule exerting a relaxation effect on vascular smooth muscles, and a molecule able to supply an exogenous phosphate input; treating hypoxia, e.g., neonatal diarrhea and endotoxic shock in ruminants. |
| 02/19/2004 | US20040033260 Comprise both chelated and unchelated zinc ions, wherein the quantity of chelated zinc ions is at least 50% |
| 02/19/2004 | US20040033247 Composition in the form of an emulsion that can be used to treat plantar bromhidrosis and/or hyperhidrosis |
| 02/19/2004 | US20040033198 Methods for determining effects of maternal treatments on offspring |
| 02/19/2004 | US20040031420 Quick-setting, for use in dental and bone prosthesis; calcium phosphate particles having whiskers or fine crystals of specified size on their surface |
| 02/19/2004 | CA2495516A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 02/19/2004 | CA2495502A1 Methods for treating carbonic anhydrase mediated disorders |
| 02/19/2004 | CA2494270A1 Therapeutic combinations of erb b kinase inhibitors and antineoplastic therapies |
| 02/19/2004 | CA2494156A1 Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto |
| 02/18/2004 | EP1389122A2 Prevention of epithelial cancer |
| 02/18/2004 | EP1389102A1 Use of rare earth compounds for the prevention of kidney stone disease |
| 02/18/2004 | EP1187635B1 Anaesthetic formulation comprising an nmda-antagonist and an alpha-2 adrenergic agonist |
| 02/18/2004 | CN1476330A Polymeric micelle containing cisplatin enclosed therein and use thereof |
| 02/18/2004 | CN1475439A Grain base medicine active carbon |
| 02/18/2004 | CN1475234A Medicinal composition for treating cancer |
| 02/18/2004 | CN1475226A Application of nano copper powder in preparation of antisenility medicine |
| 02/18/2004 | CN1138550C Process of producing extracts of shark |
| 02/18/2004 | CN1138541C Pharmaceutically stable oxaliplatinum prepn. |
| 02/18/2004 | CN1138505C Anti-angiogenic compositions and method of use |
| 02/17/2004 | US6693129 A biochemical formulation comprising ascorbic acid, niacin, lysine, and proline useful for lowering plasma concentration of a lipoprotein in mammal |
| 02/17/2004 | US6693127 Pharmaceutical compositions of arglabin and arglabin derivatives |
| 02/17/2004 | US6692777 Pharmaceutical composition for the treatment of diabetes mellitus |
| 02/17/2004 | US6692775 Bactericidal gel and method for treating burns and dermal lesions |
| 02/17/2004 | US6692773 Treatment of hyperproliferative skin disorders and diseases |
| 02/17/2004 | US6692772 Administered between 15 and 90 minutes prior to exposure of the subject to thrombogenic stimuli |
| 02/12/2004 | WO2004012754A1 Composition for accelerating secretion of estrogen and regenerating tissue cells of female sexual organs |
| 02/12/2004 | WO2004012749A1 An analgesic agent for newborn or fetal subjects |
| 02/12/2004 | WO2004012748A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 02/12/2004 | US20040029853 Therapy for gastrointestinal disorders |
| 02/12/2004 | US20040029852 Anticancer agents |
| 02/12/2004 | US20040029751 Preparatiom for douches and/or irrigations of natural or pathological cavities in the human body |
| 02/12/2004 | US20040028759 Pharmaceutical or dietary composition containing a vegetable oil, in particular olive oil and sitosterol |
| 02/12/2004 | US20040028753 Inhalation of nitric oxide |
| 02/12/2004 | US20040028751 Compositions for preventing or ameliorating multiple risk factor syndromes |
| 02/12/2004 | US20040028750 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 02/12/2004 | US20040028749 Treating inflammation and associated complications |
| 02/12/2004 | US20040028748 Remedies for dermatophytosis |
| 02/12/2004 | US20040028676 In situ injecting biocompatible particle mixture with carrier; enlarging breathing passageways |
| 02/12/2004 | US20040026237 Ionization device which is mounted with gold pole or silver pole |
| 02/12/2004 | DE10251709A1 Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 und kosmetische oder pharmazeutische Zusammensetzungen, die solche Wirkstoffe enthalten Agents for stimulating the human beta-defensins type 2 and / or Type 3 and cosmetic or pharmaceutical compositions containing such active |
| 02/12/2004 | DE10235602A1 Use of transition metal cluster compounds capable of interacting with DNA to prevent or treat human or animal diseases, especially tumors |
| 02/12/2004 | CA2494378A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing |
| 02/11/2004 | EP1387689A1 Combination of a gelatinase inhibitor and an anti-tumor agent, and uses thereof |
| 02/11/2004 | EP1231908B1 Pharmaceutical composition comprising a no donor compound and its use |
| 02/11/2004 | EP1091747B1 Use of iso-osmotic saline solutions for the prevention of inflammation |
| 02/11/2004 | EP1089620B1 Hydrophilic polymer blends used to prevent cow skin infections |